Literature DB >> 10194837

Optimisation of the immune response to foot-and-mouth disease vaccines.

T R Doel1.   

Abstract

Considering the many variables influencing the immune response of the host to vaccination against foot-and-mouth disease (FMD), the properties and characteristics of the vaccine and recommendations concerning its mode of application offer the best opportunity for the manufacturer to provide safe, effective protection of livestock. There are a number of critical elements in the production of FMD vaccines, such as the selection of appropriate strain(s), which have a direct bearing on the quality of the immune response. Equally, development of effective immunity depends on proper and timely application of good quality vaccine. In contrast, several of the potential variables in vaccination against FMD such as the use of oil adjuvants for cattle are probably less critical than is sometimes perceived. This presentation considers some of the many variables involved in the production and use of FMD vaccines.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194837     DOI: 10.1016/s0264-410x(98)00444-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  Vaccination against foot-and-mouth disease: the implications for Canada.

Authors:  Sarah Kahn; Dorothy W Geale; Paul R Kitching; Alice Bouffard; Denis G Allard; J Robert Duncan
Journal:  Can Vet J       Date:  2002-05       Impact factor: 1.008

2.  The impact of local heterogeneity on alternative control strategies for foot-and-mouth disease.

Authors:  Rowland R Kao
Journal:  Proc Biol Sci       Date:  2003-12-22       Impact factor: 5.349

3.  Seroprevalence of foot-and-mouth disease in the southern provinces of Cambodia.

Authors:  Sothyra Tum; Ian Ducan Robertson; John Edwards; Ronello Abila; Subhash Morzaria
Journal:  Trop Anim Health Prod       Date:  2015-01-24       Impact factor: 1.559

4.  Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: rate of development of immunity and variations among other ruminants.

Authors:  Prasanna K Patil; Jagadeesh Bayry; Chitimalla Ramakrishna; Basavesh Hugar; Laxmi D Misra; Krishnamsetty Prabhudas; C Natarajan
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  A serological survey for antibodies against foot-and-mouth disease virus (FMDV) in domestic pigs during outbreaks in Kenya.

Authors:  Sabenzia N Wekesa; Alice Namatovu; Abraham K Sangula; Moses T Dhikusooka; Vincent B Muwanika; Kirsten Tjørnehøj
Journal:  Trop Anim Health Prod       Date:  2014-01-18       Impact factor: 1.559

6.  Serosurveillance of foot and mouth disease in Karnataka state, India: a 3 years study.

Authors:  Raveendra Hegde; Srikanth Kowalli; K Nagaraja; N K Dharanesha; C M Seema; Tanveer Ahmed Khan; G V Nagaraj; K Srikala; K J Sudharshana; D Nagaraju; Shesha Rao; P Giridhara; S M Byregowda
Journal:  Virusdisease       Date:  2016-08-26

7.  Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response.

Authors:  David Schley; Reiko J Tanaka; Kritsada Leungchavaphongse; Vahid Shahrezaei; John Ward; Clare Grant; Bryan Charleston; Christopher J Rhodes
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

8.  Supplementation of dietary germanium biotite enhances induction of the immune responses by foot-and-mouth disease vaccine in cattle.

Authors:  Myunghwan Jung; Min-Kyoung Shin; Seung-Bin Cha; Seung Won Shin; Anna Yoo; Won-Jung Lee; Hong-Tae Park; Jong-Hyeon Park; Byounghan Kim; Yeon-Kwon Jung; Han Sang Yoo
Journal:  BMC Vet Res       Date:  2014-08-12       Impact factor: 2.741

Review 9.  Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review.

Authors:  Sarah J Cox; Paul V Barnett
Journal:  Vet Res       Date:  2008-12-02       Impact factor: 3.683

10.  Requirements for improved vaccines against foot-and-mouth disease epidemics.

Authors:  Jong-Hyeon Park
Journal:  Clin Exp Vaccine Res       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.